
A systematic review from Erasmus University in the Netherlands reveals the potential benefits and risks of medicinal cannabis in treating conditions such as anxiety, depression, and PTSD, highlighting the importance of personalized approaches in mental health.

Event brings together over 100 speakers and establishes itself as the largest in Latin America in medicinal cannabis

Councilman André Fraga demands urgency and says there is a "lack of will" to put the measure into practice

Experts point out regulatory and operational bottlenecks that challenge the consolidation of the national market, even after the advances of RDC 660/2022

In 2024, the sector generated R$ 853 million, representing a 22% growth compared to the previous year

Medicinal cannabis has been associated with improvements in activities such as shopping, food preparation, housekeeping, and medication management

The change represents a remarkable turnaround for the country, which was once famous as a major center for marijuana trafficking in Europe

Director of Institutional Relations evaluates national cultivation, new RDCs from Anvisa, and the challenges to consolidate the sector in the country

Ministry of Health extends deadline to avoid treatment interruptions in 2026; industry demands permanent law already validated by the EU

Debates promoted by Padre Pedro in Western Santa Catarina broaden the discussion on the medicinal use of cannabis, bringing together experts, patients, and the community to address access, treatments, and public policies in Santa Catarina

Unesp researcher expands boundaries: Rogério Amorim leads studies on cannabis and cognitive dysfunction in dogs

Selected by SUPERA Park, Canabinote aims to mitigate medical uncertainty with technology based on scientific evidence and commercial neutrality

New decree expands domestic market and aims to promote production, processing, and exportation, according to the director of the National Narcotics Fund

Initiative by deputy Paulinha aims to train public network professionals for safe prescription; launch event takes place this Thursday (30)

Free event discusses therapeutic use in the SUS, addressing clinical and legal aspects for doctors, nurses, and students

New formulations arrive in balanced (1:1) and isolated (300 mg) versions, focusing on quality of life, safety, and treatment customization

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.

The initiative prepares future healthcare professionals with practice, science, and responsibility

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

Patients with ASD, fibromyalgia, and chronic pain will be able to access cannabidiol-based medications through the public network